Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock par value $0.001 per share
-
Shares outstanding
-
133,936,717
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
7,393,156
-
Shares change
-
-305,065
-
Total reported value, excl. options
-
$41,919,393
-
Value change
-
-$3,040,105
-
Number of buys
-
27
-
Number of sells
-
-16
-
Price
-
$5.67
Significant Holders of Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) as of Q3 2018
55 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock par value $0.001 per share as of Q3 2018.
Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,393,156 shares
of 133,936,717 outstanding shares and own 5.5% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,487,755 shares), FMR LLC (1,015,805 shares), Redmile Group, LLC (730,150 shares), COWEN INC. (707,643 shares), Tekla Capital Management LLC (535,824 shares), Vanguard Group Inc (446,770 shares), OppenheimerFunds, Inc. (424,580 shares), DEUTSCHE BANK AG\ (248,452 shares), BAKER BROS. ADVISORS LP (222,139 shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (211,107 shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.